{"count":221272,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1028","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1026","results":[{"created":"2022-01-24T20:26:34.464702+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1428","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CSNK2B was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:25:37.797980+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1427","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CSNK2B: Rating: GREEN; Mode of pathogenicity: None; Publications: 28585349, 28762608; Phenotypes: Poirier-Bienvenu neurodevelopmental syndrome , MIM#618732; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:24:44.216601+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4464","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CSNK2B as ready","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:24:44.205668+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4464","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: csnk2b has been classified as Green List (High Evidence).","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:24:35.835937+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4464","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CSNK2B were changed from  to Poirier-Bienvenu neurodevelopmental syndrome , MIM#618732","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:24:01.819785+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4463","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CSNK2B were set to ","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:23:27.578310+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4462","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CSNK2B was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:22:58.639819+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4461","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CSNK2B: Rating: GREEN; Mode of pathogenicity: None; Publications: 28585349, 28762608; Phenotypes: Poirier-Bienvenu neurodevelopmental syndrome , MIM#618732; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:21:49.301901+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10783","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CSNK2B as ready","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:21:49.291016+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10783","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: csnk2b has been classified as Green List (High Evidence).","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:21:38.978096+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10783","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CSNK2B were changed from  to Poirier-Bienvenu neurodevelopmental syndrome , MIM#618732","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:21:14.400189+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10782","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CSNK2B were set to ","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:20:51.201913+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10781","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CSNK2B was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:20:30.712090+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10780","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CSNK2B: Rating: GREEN; Mode of pathogenicity: None; Publications: 28585349, 28762608; Phenotypes: Poirier-Bienvenu neurodevelopmental syndrome , MIM#618732; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"CSNK2B","entity_type":"gene"},{"created":"2022-01-24T20:14:54.188869+11:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNU4ATAC as ready","entity_name":"RNU4ATAC","entity_type":"gene"},{"created":"2022-01-24T20:14:54.179488+11:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnu4atac has been classified as Green List (High Evidence).","entity_name":"RNU4ATAC","entity_type":"gene"},{"created":"2022-01-24T20:14:53.713349+11:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RNU4ATAC as ready","entity_name":"RNU4ATAC","entity_type":"gene"},{"created":"2022-01-24T20:14:53.701190+11:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnu4atac has been classified as Green List (High Evidence).","entity_name":"RNU4ATAC","entity_type":"gene"},{"created":"2022-01-24T20:14:39.495652+11:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: RNU4ATAC as Green List (high evidence)","entity_name":"RNU4ATAC","entity_type":"gene"},{"created":"2022-01-24T20:14:39.484312+11:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rnu4atac has been classified as Green List (High Evidence).","entity_name":"RNU4ATAC","entity_type":"gene"},{"created":"2022-01-24T20:14:23.858615+11:00","panel_name":"Syndromic Retinopathy","panel_id":3099,"panel_version":"0.184","user_name":"Zornitza Stark","item_type":"entity","text":"gene: RNU4ATAC was added\ngene: RNU4ATAC was added to Syndromic Retinopathy. Sources: Expert Review\nMode of inheritance for gene: RNU4ATAC was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: RNU4ATAC were set to 2801768; 29265708; 30368667\nPhenotypes for gene: RNU4ATAC were set to Roifman syndrome, MIM#\t616651; Lowry-Wood syndrome, MIM#\t226960\nReview for gene: RNU4ATAC was set to GREEN\nAdded comment: Retinal dystrophy reported. \nSources: Expert Review","entity_name":"RNU4ATAC","entity_type":"gene"},{"created":"2022-01-24T20:09:51.893235+11:00","panel_name":"Anophthalmia_Microphthalmia_Coloboma","panel_id":42,"panel_version":"1.12","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PACS1 as ready","entity_name":"PACS1","entity_type":"gene"},{"created":"2022-01-24T20:09:51.875750+11:00","panel_name":"Anophthalmia_Microphthalmia_Coloboma","panel_id":42,"panel_version":"1.12","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pacs1 has been classified as Green List (High Evidence).","entity_name":"PACS1","entity_type":"gene"},{"created":"2022-01-24T20:09:47.156170+11:00","panel_name":"Anophthalmia_Microphthalmia_Coloboma","panel_id":42,"panel_version":"1.12","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PACS1 were changed from 615009 to Schuurs-Hoeijmakers syndrome, MIM#\t615009","entity_name":"PACS1","entity_type":"gene"},{"created":"2022-01-24T20:08:59.599609+11:00","panel_name":"Anophthalmia_Microphthalmia_Coloboma","panel_id":42,"panel_version":"1.11","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PACS1 as Green List (high evidence)","entity_name":"PACS1","entity_type":"gene"},{"created":"2022-01-24T20:08:59.587361+11:00","panel_name":"Anophthalmia_Microphthalmia_Coloboma","panel_id":42,"panel_version":"1.11","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pacs1 has been classified as Green List (High Evidence).","entity_name":"PACS1","entity_type":"gene"},{"created":"2022-01-24T20:07:19.192054+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10780","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NCAPD3 as ready","entity_name":"NCAPD3","entity_type":"gene"},{"created":"2022-01-24T20:07:19.181901+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10780","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ncapd3 has been classified as Amber List (Moderate Evidence).","entity_name":"NCAPD3","entity_type":"gene"},{"created":"2022-01-24T20:07:11.195244+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10780","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NCAPD3 were changed from  to Microcephaly 22, primary, autosomal recessive, MIM# 617984","entity_name":"NCAPD3","entity_type":"gene"},{"created":"2022-01-24T20:06:51.505079+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10779","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NCAPD3 were set to ","entity_name":"NCAPD3","entity_type":"gene"},{"created":"2022-01-24T20:06:31.218403+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10778","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NCAPD3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NCAPD3","entity_type":"gene"},{"created":"2022-01-24T20:06:11.062133+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10777","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NCAPD3 as Amber List (moderate evidence)","entity_name":"NCAPD3","entity_type":"gene"},{"created":"2022-01-24T20:06:11.051064+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10777","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ncapd3 has been classified as Amber List (Moderate Evidence).","entity_name":"NCAPD3","entity_type":"gene"},{"created":"2022-01-24T20:05:53.158414+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10776","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NCAPD3: Rating: AMBER; Mode of pathogenicity: None; Publications: 27737959; Phenotypes: Microcephaly 22, primary, autosomal recessive, MIM# 617984; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NCAPD3","entity_type":"gene"},{"created":"2022-01-24T19:06:56.305688+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLC5A6 as ready","entity_name":"SLC5A6","entity_type":"gene"},{"created":"2022-01-24T19:06:56.295060+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc5a6 has been classified as Green List (High Evidence).","entity_name":"SLC5A6","entity_type":"gene"},{"created":"2022-01-24T19:06:48.968306+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SLC5A6 as Green List (high evidence)","entity_name":"SLC5A6","entity_type":"gene"},{"created":"2022-01-24T19:06:48.958734+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc5a6 has been classified as Green List (High Evidence).","entity_name":"SLC5A6","entity_type":"gene"},{"created":"2022-01-24T19:06:33.824246+11:00","panel_name":"Hereditary Neuropathy - complex","panel_id":3070,"panel_version":"0.118","user_name":"Zornitza Stark","item_type":"entity","text":"gene: SLC5A6 was added\ngene: SLC5A6 was added to Hereditary Neuropathy - complex. Sources: Literature\nMode of inheritance for gene: SLC5A6 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: SLC5A6 were set to 35013551\nPhenotypes for gene: SLC5A6 were set to Neurodegeneration, infantile-onset, biotin-responsive, MIM#\t618973\nReview for gene: SLC5A6 was set to GREEN\nAdded comment: Multi-system potentially treatable disorder.\r\n\r\nFive individuals from three families reported with motor neuropathies. \nSources: Literature","entity_name":"SLC5A6","entity_type":"gene"},{"created":"2022-01-24T19:02:56.927825+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10776","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CYP2C8 as ready","entity_name":"CYP2C8","entity_type":"gene"},{"created":"2022-01-24T19:02:56.917773+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10776","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp2c8 has been classified as Red List (Low Evidence).","entity_name":"CYP2C8","entity_type":"gene"},{"created":"2022-01-24T19:02:48.848929+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10776","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CYP2C8 were changed from  to {Drug metabolism, altered, CYP2C8-related} 618018","entity_name":"CYP2C8","entity_type":"gene"},{"created":"2022-01-24T19:02:30.473736+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10775","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CYP2C8 as Red List (low evidence)","entity_name":"CYP2C8","entity_type":"gene"},{"created":"2022-01-24T19:02:30.457780+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10775","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cyp2c8 has been classified as Red List (Low Evidence).","entity_name":"CYP2C8","entity_type":"gene"},{"created":"2022-01-24T19:02:12.444755+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10774","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CYP2C8: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: {Drug metabolism, altered, CYP2C8-related} 618018; Mode of inheritance: None","entity_name":"CYP2C8","entity_type":"gene"},{"created":"2022-01-24T18:56:29.321288+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2749","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MED25 as ready","entity_name":"MED25","entity_type":"gene"},{"created":"2022-01-24T18:56:29.311409+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2749","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: med25 has been classified as Green List (High Evidence).","entity_name":"MED25","entity_type":"gene"},{"created":"2022-01-24T18:56:21.576146+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2749","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MED25 as Green List (high evidence)","entity_name":"MED25","entity_type":"gene"},{"created":"2022-01-24T18:56:21.556485+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2749","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: med25 has been classified as Green List (High Evidence).","entity_name":"MED25","entity_type":"gene"},{"created":"2022-01-24T18:55:42.941342+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2748","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SHMT2 as ready","entity_name":"SHMT2","entity_type":"gene"},{"created":"2022-01-24T18:55:42.931826+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2748","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: shmt2 has been classified as Green List (High Evidence).","entity_name":"SHMT2","entity_type":"gene"},{"created":"2022-01-24T18:55:34.570515+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2748","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SHMT2 as Green List (high evidence)","entity_name":"SHMT2","entity_type":"gene"},{"created":"2022-01-24T18:55:34.554763+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2748","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: shmt2 has been classified as Green List (High Evidence).","entity_name":"SHMT2","entity_type":"gene"},{"created":"2022-01-24T18:55:08.377044+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2747","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAST1 as ready","entity_name":"MAST1","entity_type":"gene"},{"created":"2022-01-24T18:55:08.364617+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2747","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mast1 has been classified as Green List (High Evidence).","entity_name":"MAST1","entity_type":"gene"},{"created":"2022-01-24T18:54:59.645407+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2747","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MAST1 as Green List (high evidence)","entity_name":"MAST1","entity_type":"gene"},{"created":"2022-01-24T18:54:59.634657+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2747","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mast1 has been classified as Green List (High Evidence).","entity_name":"MAST1","entity_type":"gene"},{"created":"2022-01-24T18:54:33.406119+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2746","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAPK8IP3 as ready","entity_name":"MAPK8IP3","entity_type":"gene"},{"created":"2022-01-24T18:54:33.395342+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2746","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mapk8ip3 has been classified as Green List (High Evidence).","entity_name":"MAPK8IP3","entity_type":"gene"},{"created":"2022-01-24T18:54:24.557728+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2746","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MAPK8IP3 as Green List (high evidence)","entity_name":"MAPK8IP3","entity_type":"gene"},{"created":"2022-01-24T18:54:24.545884+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2746","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mapk8ip3 has been classified as Green List (High Evidence).","entity_name":"MAPK8IP3","entity_type":"gene"},{"created":"2022-01-24T18:53:59.299224+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2745","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAP1B as ready","entity_name":"MAP1B","entity_type":"gene"},{"created":"2022-01-24T18:53:59.288793+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2745","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: map1b has been classified as Green List (High Evidence).","entity_name":"MAP1B","entity_type":"gene"},{"created":"2022-01-24T18:53:54.826604+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2745","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MAP1B were changed from polymicrogyria; PVNH; Periventricular nodular heterotopia 9, MIM# 618918 to Polymicrogyria; Periventricular nodular heterotopia 9, MIM# 618918","entity_name":"MAP1B","entity_type":"gene"},{"created":"2022-01-24T18:53:27.453038+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2744","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MAP1B as Green List (high evidence)","entity_name":"MAP1B","entity_type":"gene"},{"created":"2022-01-24T18:53:27.443149+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2744","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: map1b has been classified as Green List (High Evidence).","entity_name":"MAP1B","entity_type":"gene"},{"created":"2022-01-24T18:52:55.647480+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2743","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ASTN1 as ready","entity_name":"ASTN1","entity_type":"gene"},{"created":"2022-01-24T18:52:55.636950+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2743","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: astn1 has been classified as Amber List (Moderate Evidence).","entity_name":"ASTN1","entity_type":"gene"},{"created":"2022-01-24T18:52:51.568544+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2743","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ASTN1 were set to 29706646; 11861479","entity_name":"ASTN1","entity_type":"gene"},{"created":"2022-01-24T18:52:38.203739+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2742","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ASTN1 as Amber List (moderate evidence)","entity_name":"ASTN1","entity_type":"gene"},{"created":"2022-01-24T18:52:38.194735+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2742","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: astn1 has been classified as Amber List (Moderate Evidence).","entity_name":"ASTN1","entity_type":"gene"},{"created":"2022-01-24T18:52:01.699678+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2741","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PDE3A as ready","entity_name":"PDE3A","entity_type":"gene"},{"created":"2022-01-24T18:52:01.686896+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2741","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pde3a has been classified as Green List (High Evidence).","entity_name":"PDE3A","entity_type":"gene"},{"created":"2022-01-24T18:51:56.556213+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2741","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: PDE3A as Green List (high evidence)","entity_name":"PDE3A","entity_type":"gene"},{"created":"2022-01-24T18:51:56.542358+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2741","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pde3a has been classified as Green List (High Evidence).","entity_name":"PDE3A","entity_type":"gene"},{"created":"2022-01-24T18:51:13.493922+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2740","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HYAL1 as ready","entity_name":"HYAL1","entity_type":"gene"},{"created":"2022-01-24T18:51:13.483333+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2740","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hyal1 has been classified as Red List (Low Evidence).","entity_name":"HYAL1","entity_type":"gene"},{"created":"2022-01-24T18:51:04.717566+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2740","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HYAL1 were changed from MUCOPOLYSACCHARIDOSIS TYPE 9 to Mucopolysaccharidosis type IX, MIM# 601492; MONDO:0011093","entity_name":"HYAL1","entity_type":"gene"},{"created":"2022-01-24T18:50:51.159873+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2739","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HYAL1 were set to ","entity_name":"HYAL1","entity_type":"gene"},{"created":"2022-01-24T18:50:16.370882+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2738","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FMN1 as ready","entity_name":"FMN1","entity_type":"gene"},{"created":"2022-01-24T18:50:16.361145+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2738","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fmn1 has been classified as Amber List (Moderate Evidence).","entity_name":"FMN1","entity_type":"gene"},{"created":"2022-01-24T18:50:01.672355+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2738","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FMN1 as Amber List (moderate evidence)","entity_name":"FMN1","entity_type":"gene"},{"created":"2022-01-24T18:50:01.659172+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2738","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fmn1 has been classified as Amber List (Moderate Evidence).","entity_name":"FMN1","entity_type":"gene"},{"created":"2022-01-24T18:49:24.352767+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2737","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HSD17B10 as ready","entity_name":"HSD17B10","entity_type":"gene"},{"created":"2022-01-24T18:49:24.342186+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2737","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hsd17b10 has been classified as Amber List (Moderate Evidence).","entity_name":"HSD17B10","entity_type":"gene"},{"created":"2022-01-24T18:49:17.663579+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2737","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HSD17B10 were changed from 2-METHYL-3-HYDROXYBUTYRYL-COA DEHYDROGENASE DEFICIENCY; MENTAL RETARDATION SYNDROMIC X-LINKED TYPE 10 to HSD10 mitochondrial disease, MIM# 300438","entity_name":"HSD17B10","entity_type":"gene"},{"created":"2022-01-24T18:47:55.382510+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2736","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: HSD17B10 as Amber List (moderate evidence)","entity_name":"HSD17B10","entity_type":"gene"},{"created":"2022-01-24T18:47:55.371742+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2736","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hsd17b10 has been classified as Amber List (Moderate Evidence).","entity_name":"HSD17B10","entity_type":"gene"},{"created":"2022-01-24T18:47:11.225840+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2735","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HPGD as ready","entity_name":"HPGD","entity_type":"gene"},{"created":"2022-01-24T18:47:11.213295+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2735","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hpgd has been classified as Red List (Low Evidence).","entity_name":"HPGD","entity_type":"gene"},{"created":"2022-01-24T18:47:01.967587+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2735","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HPGD were changed from CRANIOOSTEOARTHROPATHY to Hypertrophic osteoarthropathy, primary, autosomal recessive 1 MIM#259100; Cranioosteoarthropathy MIM#259100","entity_name":"HPGD","entity_type":"gene"},{"created":"2022-01-24T18:46:49.492065+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2734","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HPGD were set to ","entity_name":"HPGD","entity_type":"gene"},{"created":"2022-01-24T18:46:17.877110+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2733","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FAT1 as ready","entity_name":"FAT1","entity_type":"gene"},{"created":"2022-01-24T18:46:17.864913+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2733","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fat1 has been classified as Green List (High Evidence).","entity_name":"FAT1","entity_type":"gene"},{"created":"2022-01-24T18:46:09.822493+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2733","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FAT1 as Green List (high evidence)","entity_name":"FAT1","entity_type":"gene"},{"created":"2022-01-24T18:46:09.812587+11:00","panel_name":"Fetal anomalies","panel_id":3763,"panel_version":"0.2733","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fat1 has been classified as Green List (High Evidence).","entity_name":"FAT1","entity_type":"gene"},{"created":"2022-01-24T18:45:39.372518+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10774","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HPGD as ready","entity_name":"HPGD","entity_type":"gene"},{"created":"2022-01-24T18:45:39.360085+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10774","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hpgd has been classified as Green List (High Evidence).","entity_name":"HPGD","entity_type":"gene"},{"created":"2022-01-24T18:45:29.778048+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10774","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HPGD were changed from  to Hypertrophic osteoarthropathy, primary, autosomal recessive 1 MIM#259100; Cranioosteoarthropathy MIM#259100","entity_name":"HPGD","entity_type":"gene"},{"created":"2022-01-24T18:44:59.453383+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.10773","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: HPGD were set to ","entity_name":"HPGD","entity_type":"gene"}]}